{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:05:55Z","timestamp":1793747155154,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Minufiya University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitiligo is an acquired and progressive mucocutaneous disease with the damage of functioning epidermal melanocytes. Metabolic syndrome is associated with inflammatory skin diseases incorporating vitiligo. The circadian dysfunction triggers the pathogenesis of metabolic diseases, so our study aimed to determine the relationship between aryl hydrocarbon receptor nuclear translocator-like gene, a ligand-activated transcription factor and sensor of environmental chemicals, expression and polymorphism with non-segmental vitiligo, as well as its effect on lipid profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case-control study was handled on 50 non-segmental vitiligo patients (generalized (12) and localized type (focal; 24 and acrofacial; 14)) and 50 matched controls. Each subject was proposed for full history taking, clinical examinations, serum lipid profile, and measurement of BMAL1 gene expression in the blood, and BMAL1 rs2279287 polymorphism of DNA extract from whole blood by real time-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified that total cholesterol, triglyceride, and low-density lipoprotein were significantly higher, but high-density lipoprotein was significantly lower in non-segmental vitiligo patients than in the control group. A significant increase in circadian gene expression in non-segmental vitiligo patients was observed, with more detection of the BMAL1 T\/C genotype (92%) than the T\/T genotype. There was a significant positive relationship between the level of the circadian gene and the vitiligo patient\u2019s age, age of onset, and VIDA Score. The level of the circadian gene at Cutoff\u00a0\u2009\u2265\u20091.16 can predict the prognosis of vitiligo with a sensitivity of 78%, specificity of 84%, and accuracy of 81%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The circadian gene has an active role in the progress of non-segmental vitiligo and targeting this gene could have a significant impact on its management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11033-023-09109-6","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T10:03:49Z","timestamp":1705572229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Circadian clock gene expression and polymorphism in non-segmental vitiligo"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0333-5506","authenticated-orcid":false,"given":"Azza Gaber Antar","family":"Farag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-1596","authenticated-orcid":false,"given":"Eman A. E.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1180-1845","authenticated-orcid":false,"given":"Asmaa Fahmy","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"9109_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/J.JID.2017.08.038","volume":"138","author":"K Boniface","year":"2018","unstructured":"Boniface K, Jacquemin C, Darrigade AS et al (2018) Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3. J Invest Dermatol 138:355\u2013364. https:\/\/doi.org\/10.1016\/J.JID.2017.08.038","journal-title":"J Invest Dermatol"},{"key":"9109_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","volume":"38","author":"R Yaghoobi","year":"2011","unstructured":"Yaghoobi R, Omidian M, Bagherani N (2011) Vitiligo: a review of the published work. J Dermatol 38:419\u2013431. https:\/\/doi.org\/10.1111\/j.1346-8138.2010.01139.x","journal-title":"J Dermatol"},{"key":"9109_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/PCMR.12848","volume":"33","author":"GHL Roberts","year":"2020","unstructured":"Roberts GHL, Santorico SA, Spritz RA (2020) The genetic architecture of vitiligo. Pigment Cell Melanoma Res 33:8\u201315. https:\/\/doi.org\/10.1111\/PCMR.12848","journal-title":"Pigment Cell Melanoma Res"},{"key":"9109_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.568447","volume":"11","author":"R Speeckaert","year":"2020","unstructured":"Speeckaert R, Lambert J, Bulat V et al (2020) Autoimmunity in segmental vitiligo. Front Immunol 11:568447. https:\/\/doi.org\/10.3389\/FIMMU.2020.568447","journal-title":"Front Immunol"},{"key":"9109_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/S41583-018-0088-Y","volume":"20","author":"RW Logan","year":"2019","unstructured":"Logan RW, McClung CA (2019) Rhythms of life: circadian disruption and brain disorders across the lifespan. Nat Rev Neurosci 20:49\u201365. https:\/\/doi.org\/10.1038\/S41583-018-0088-Y","journal-title":"Nat Rev Neurosci"},{"key":"9109_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1146\/ANNUREV-PHYSIOL-073109-130051","volume":"72","author":"H Ukai","year":"2010","unstructured":"Ukai H, Ueda HR (2010) Systems biology of mammalian circadian clocks. Annu Rev Physiol 72:579\u2013603. https:\/\/doi.org\/10.1146\/ANNUREV-PHYSIOL-073109-130051","journal-title":"Annu Rev Physiol"},{"key":"9109_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/ANNUREV.PHYSIOL.63.1.647","volume":"63","author":"SM Reppert","year":"2001","unstructured":"Reppert SM, Weaver DR (2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647\u2013676. https:\/\/doi.org\/10.1146\/ANNUREV.PHYSIOL.63.1.647","journal-title":"Annu Rev Physiol"},{"key":"9109_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/B978-0-12-396971-2.00010-5","volume":"119","author":"JA Evans","year":"2013","unstructured":"Evans JA, Davidson AJ (2013) Health consequences of circadian disruption in humans and animal models. Prog Mol Biol Transl Sci 119:283\u2013323. https:\/\/doi.org\/10.1016\/B978-0-12-396971-2.00010-5","journal-title":"Prog Mol Biol Transl Sci"},{"key":"9109_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/J.CELL.2020.11.034","volume":"184","author":"C L\u00f3pez-Ot\u00edn","year":"2021","unstructured":"L\u00f3pez-Ot\u00edn C, Kroemer G (2021) Hallmarks of health. Cell 184:33\u201363. https:\/\/doi.org\/10.1016\/J.CELL.2020.11.034","journal-title":"Cell"},{"key":"9109_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/ARCHDERM.140.6.677","volume":"140","author":"I Hamzavi","year":"2004","unstructured":"Hamzavi I, Jain H, McLean D et al (2004) Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the vitiligo area scoring index. Arch Dermatol 140:677\u2013683. https:\/\/doi.org\/10.1001\/ARCHDERM.140.6.677","journal-title":"Arch Dermatol"},{"key":"9109_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.21608\/zumj.2019.30922","volume":"25","author":"MIA Gamil","year":"2019","unstructured":"Gamil MIA, Mh K MHF (2019) Histopathological findings in lesional and perilesional skin of vitiligo patients before and after narrow band ultraviolet B phototherapy. Zagazig Univ Med J 25:326\u2013334","journal-title":"Zagazig Univ Med J"},{"key":"9109_CR12","unstructured":"WHO (2021) https:\/\/www.WHO.int\/data\/gho\/body-mass-index"},{"key":"9109_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/J.PEDNEO.2016.03.008","volume":"58","author":"CM Ma","year":"2017","unstructured":"Ma CM, Yin FZ, Liu XL et al (2017) How to simplify the diagnostic criteria of metabolic syndrome in adolescents. Pediatr Neonatol 58:178\u2013184. https:\/\/doi.org\/10.1016\/J.PEDNEO.2016.03.008","journal-title":"Pediatr Neonatol"},{"key":"9109_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-016-2224-y","author":"J Aarem","year":"2016","unstructured":"Aarem J, Brunborg G, Aas KK et al (2016) Comparison of blood RNA isolation methods from samples stabilized in tempus tubes and stored at a large human biobank. BMC Res Notes. https:\/\/doi.org\/10.1186\/s13104-016-2224-y","journal-title":"BMC Res Notes"},{"key":"9109_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/NPROT.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101\u20131108. https:\/\/doi.org\/10.1038\/NPROT.2008.73","journal-title":"Nat Protoc"},{"key":"9109_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU13020541","volume":"13","author":"O Coltell","year":"2021","unstructured":"Coltell O, Ortega-Azor\u00edn C, Sorl\u00ed JV et al (2021) Circulating adiponectin and its association with metabolic traits and type 2 diabetes: gene-diet interactions focusing on selected gene variants and at the genome-wide level in high-cardiovascular risk mediterranean subjects. Nutrients 13:1\u201324. https:\/\/doi.org\/10.3390\/NU13020541","journal-title":"Nutrients"},{"key":"9109_CR17","first-page":"2278","volume":"8","author":"PN Sinha","year":"2019","unstructured":"Sinha PN (2019) Association of metabolic syndromewith vitiligo- a case control study. J Evol Med Dent Sci 8:2278\u20134802","journal-title":"J Evol Med Dent Sci"},{"key":"9109_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/1119-3077.173705","volume":"19","author":"AA Sabir","year":"2016","unstructured":"Sabir AA, Bilbis LS, Saidu Y et al (2016) Oxidative stress among subjects with metabolic syndrome in Sokoto, North-Western Nigeria. Niger J Clin Pract 19:128\u2013132. https:\/\/doi.org\/10.4103\/1119-3077.173705","journal-title":"Niger J Clin Pract"},{"key":"9109_CR19","doi-asserted-by":"publisher","first-page":"16866","DOI":"10.18632\/ONCOTARGET.4343","volume":"6","author":"DZ Kochan","year":"2015","unstructured":"Kochan DZ, Kovalchuk O (2015) Circadian disruption and breast cancer: an epigenetic link? Oncotarget 6:16866\u201316882. https:\/\/doi.org\/10.18632\/ONCOTARGET.4343","journal-title":"Oncotarget"},{"key":"9109_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3109\/07357907.2014.919305","volume":"32","author":"MD Wirth","year":"2014","unstructured":"Wirth MD, Burch JB, H\u00e9bert JR et al (2014) Case-control study of breast cancer in India: role of PERIOD3 clock gene length polymorphism and chronotype. Cancer Invest 32:321\u2013329. https:\/\/doi.org\/10.3109\/07357907.2014.919305","journal-title":"Cancer Invest"},{"key":"9109_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/S10552-014-0478-Z","volume":"26","author":"SC Markt","year":"2015","unstructured":"Markt SC, Valdimarsdottir UA, Shui IM et al (2015) Circadian clock genes and risk of fatal prostate cancer. Cancer Causes & Control: CCC 26:25\u201333. https:\/\/doi.org\/10.1007\/S10552-014-0478-Z","journal-title":"Cancer Causes & Control: CCC"},{"key":"9109_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/S12933-015-0327-8","author":"D Corella","year":"2016","unstructured":"Corella D, Asensio EM, Coltell O et al (2016) CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial. Cardiovasc Diabetol. https:\/\/doi.org\/10.1186\/S12933-015-0327-8. (Cardiovascular diabetology 15)","journal-title":"Cardiovasc Diabetol"},{"key":"9109_CR23","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3109\/07420528.2015.1060603","volume":"32","author":"F Benedetti","year":"2015","unstructured":"Benedetti F, Riccaboni R, Dallaspezia S et al (2015) Effects of CLOCK gene variants and early stress on hopelessness and suicide in bipolar depression. Chronobiol Int 32:1156\u20131161. https:\/\/doi.org\/10.3109\/07420528.2015.1060603","journal-title":"Chronobiol Int"},{"key":"9109_CR24","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/CAM4.2050","volume":"8","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wang D, Song Y et al (2019) Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer. Cancer Med 8:1919\u20131929. https:\/\/doi.org\/10.1002\/CAM4.2050","journal-title":"Cancer Med"},{"key":"9109_CR25","doi-asserted-by":"publisher","first-page":"153473542210960","DOI":"10.1177\/15347354221096080","volume":"21","author":"H Zhang","year":"2022","unstructured":"Zhang H, Liu R, Zhang B et al (2022) Advances in the study of circadian genes in Non-small cell lung cancer. Integr cancer Ther 21:153473542210960. https:\/\/doi.org\/10.1177\/15347354221096080","journal-title":"Integr cancer Ther"},{"key":"9109_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/JOCD.13451","volume":"20","author":"R El-Husseiny","year":"2021","unstructured":"El-Husseiny R, Abd-Elhaleem A, Salah El-Din W, Abdallah M (2021) Childhood vitiligo in egypt: clinico-epidemiologic profile of 483 patients. J Cosmet Dermatol 20:237\u2013242. https:\/\/doi.org\/10.1111\/JOCD.13451","journal-title":"J Cosmet Dermatol"},{"key":"9109_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3349\/YMJ.2015.56.3.719","volume":"56","author":"H Lee","year":"2015","unstructured":"Lee H, Lee MH, Lee DY et al (2015) Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J 56:719\u2013725. https:\/\/doi.org\/10.3349\/YMJ.2015.56.3.719","journal-title":"Yonsei Med J"},{"key":"9109_CR28","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/J.JAAD.2009.06.081","volume":"62","author":"J Mazereeuw-Hautier","year":"2010","unstructured":"Mazereeuw-Hautier J, Bezio S, Mahe E et al (2010) Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. J Am Acad Dermatol 62:945\u2013949. https:\/\/doi.org\/10.1016\/J.JAAD.2009.06.081","journal-title":"J Am Acad Dermatol"},{"key":"9109_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/PDE.12032","volume":"30","author":"S Agarwal","year":"2013","unstructured":"Agarwal S, Gupta S, Ojha A, Sinha R (2013) Childhood vitiligo: clinicoepidemiologic profile of 268 children from the Kumaun region of Uttarakhand, India. Pediatr Dermatol 30:348\u2013353. https:\/\/doi.org\/10.1111\/PDE.12032","journal-title":"Pediatr Dermatol"},{"key":"9109_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/J.AUTREV.2015.12.006","volume":"15","author":"G Iannella","year":"2016","unstructured":"Iannella G, Greco A, Didona D et al (2016) Vitiligo: pathogenesis, clinical variants and treatment approaches. Autoimmun rev 15:335\u2013343. https:\/\/doi.org\/10.1016\/J.AUTREV.2015.12.006","journal-title":"Autoimmun rev"},{"key":"9109_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/J.JAAD.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V (2011) Vitiligo: a comprehensive overview part I. introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 65:473\u2013491. https:\/\/doi.org\/10.1016\/J.JAAD.2010.11.061","journal-title":"J Am Acad Dermatol"},{"key":"9109_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/186197","volume":"2014","author":"S Patil","year":"2014","unstructured":"Patil S, Gautam M, Nadkarni N et al (2014) Gender differences in clinicoepidemiological features of vitiligo: a cross-sectional analysis. ISRN Dermatol 2014:1\u20136. https:\/\/doi.org\/10.1155\/2014\/186197","journal-title":"ISRN Dermatol"},{"key":"9109_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/11318020-000000000-00000","volume":"12","author":"X Lin","year":"2011","unstructured":"Lin X, Tang LY, Fu WW, Kang KF (2011) Childhood vitiligo in China: clinical profiles and immunological findings in 620 cases. Am J Clin Dermatol 12:277\u2013281. https:\/\/doi.org\/10.2165\/11318020-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"9109_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/J.1365-2133.2012.11002.X","volume":"167","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine K, Diallo A, L\u00e9aut\u00e9-Labr\u00e8ze C et al (2012) Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. Br J Dermatol 167:490\u2013495. https:\/\/doi.org\/10.1111\/J.1365-2133.2012.11002.X","journal-title":"Br J Dermatol"},{"key":"9109_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1034\/J.1600-0749.2003.00032.X","volume":"16","author":"A Alkhateeb","year":"2003","unstructured":"Alkhateeb A, Fain PR, Thody A et al (2003) Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families. Pigment Cell Res 16:208\u2013214. https:\/\/doi.org\/10.1034\/J.1600-0749.2003.00032.X","journal-title":"Pigment Cell Res"},{"key":"9109_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, Van Geel N (2015) Vitiligo. Lancet (London) 386:74\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(14)60763-7","journal-title":"Lancet (London)"},{"key":"9109_CR37","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1111\/PDE.13016","volume":"34","author":"XG Wu","year":"2017","unstructured":"Wu XG, Xu AE (2017) Successful treatment of vitiligo on the scalp of a 9-Year-old girl using autologous cultured pure melanocyte transplantation. Pediatr Dermatol 34:e22\u2013e23. https:\/\/doi.org\/10.1111\/PDE.13016","journal-title":"Pediatr Dermatol"},{"key":"9109_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.15537\/SMJ.2017.4.17551","volume":"38","author":"AO Al Houssien","year":"2017","unstructured":"Al Houssien AO, Al Houssien RO, Al Ajroush W, Al Kahtani HS (2017) Chronic diseases among vitiligo patients. a case control study. Saudi Med J 38:400\u2013404. https:\/\/doi.org\/10.15537\/SMJ.2017.4.17551","journal-title":"Saudi Med J"},{"issue":"Suppl 1","key":"9109_CR39","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/J.DSX.2016.12.009","volume":"11","author":"YK Sharma","year":"2017","unstructured":"Sharma YK, Bansal P, Menon S, Prakash N (2017) Metabolic syndrome in vitiligo patients among a semi-urban maharashtrian population: a case control study. Diabetes Metab Syndr 11(Suppl 1):S77\u2013S80. https:\/\/doi.org\/10.1016\/J.DSX.2016.12.009","journal-title":"Diabetes Metab Syndr"},{"key":"9109_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.ABD.2021.04.014","volume":"97","author":"AGA Farag","year":"2022","unstructured":"Farag AGA, Badr EAE, El-Shafey AESS, Elshaib ME (2022) Fatty acid-binding protein 4 circulating levels in non-segmental vitiligo. An Bras Dermatol 97:28\u201336. https:\/\/doi.org\/10.1016\/J.ABD.2021.04.014","journal-title":"An Bras Dermatol"},{"key":"9109_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/NATURE11048","volume":"485","author":"H Cho","year":"2012","unstructured":"Cho H, Zhao X, Hatori M et al (2012) Regulation of circadian behaviour and metabolism by REV-ERB-\u03b1 and REV-ERB-\u03b2. Nature 485:123\u2013127. https:\/\/doi.org\/10.1038\/NATURE11048","journal-title":"Nature"},{"key":"9109_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/J.ABD.2019.07.006","volume":"95","author":"E Tanacan","year":"2020","unstructured":"Tanacan E, Atakan N (2020) Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study. An Bras Dermatol 95:165\u2013172. https:\/\/doi.org\/10.1016\/J.ABD.2019.07.006","journal-title":"An Bras Dermatol"},{"key":"9109_CR43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4274\/BALKANMEDJ.2016.1005","volume":"34","author":"H Ata\u015f","year":"2017","unstructured":"Ata\u015f H, G\u00f6n\u00fcl M (2017) Increased risk of metabolic syndrome in patients with Vitiligo. Balkan Med J 34:219\u2013225. https:\/\/doi.org\/10.4274\/BALKANMEDJ.2016.1005","journal-title":"Balkan Med J"},{"key":"9109_CR44","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/J.1468-3083.2011.04392.X","volume":"27","author":"M Rodr\u00edguez-Mart\u00edn","year":"2013","unstructured":"Rodr\u00edguez-Mart\u00edn M, De Paz NM, Mehtani P et al (2013) Patients with vitiligo present fewer cardiovascular risk factors: results from a case\u2013control study. J Eur Acad Dermatol Venereol JEADV 27:124\u2013125. https:\/\/doi.org\/10.1111\/J.1468-3083.2011.04392.X","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"9109_CR45","doi-asserted-by":"publisher","first-page":"7170","DOI":"10.1111\/JOCD.15446","volume":"21","author":"S Ibrahim","year":"2022","unstructured":"Ibrahim S, El-Tahlawi S, Mogawer RM et al (2022) Different vitiligo characteristics as predictors of increased risk of metabolic syndrome and insulin resistance: a case-control study. J Cosmet Dermatol 21:7170\u20137177. https:\/\/doi.org\/10.1111\/JOCD.15446","journal-title":"J Cosmet Dermatol"},{"key":"9109_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/J.MATURITAS.2009.11.026","volume":"65","author":"A Cameron","year":"2010","unstructured":"Cameron A (2010) The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Maturitas 65:117\u2013121. https:\/\/doi.org\/10.1016\/J.MATURITAS.2009.11.026","journal-title":"Maturitas"},{"key":"9109_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/DDG.14717","volume":"20","author":"P Kang","year":"2022","unstructured":"Kang P, Zhang WG, Ji ZH et al (2022) Association between Vitiligo and relevant components of metabolic syndrome: a systematic review and meta-analysis. J German Soc Dermatol JDDG 20:629\u2013641. https:\/\/doi.org\/10.1111\/DDG.14717","journal-title":"J German Soc Dermatol JDDG"},{"key":"9109_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/J.CCA.2020.11.011","volume":"512","author":"H Xu","year":"2021","unstructured":"Xu H, Huang L, Zhao J et al (2021) The circadian clock and inflammation: a new insight. Clinica Chim Acta Int J Clin Chem 512:12\u201317. https:\/\/doi.org\/10.1016\/J.CCA.2020.11.011","journal-title":"Clinica Chim Acta Int J Clin Chem"},{"key":"9109_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/ijms23010121","volume":"23","author":"V N\u00e9meth","year":"2022","unstructured":"N\u00e9meth V, Horv\u00e1th S, Kiny\u00f3 \u00c1 et al (2022) Expression patterns of clock gene mRNAs and clock proteins in human psoriatic skin samples. Int J Mol Sci 23:121","journal-title":"Int J Mol Sci"},{"key":"9109_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/14397595.2019.1602242","volume":"30","author":"K Kaneshiro","year":"2020","unstructured":"Kaneshiro K, Yoshida K, Morii K et al (2020) Expressions of circadian clock genes represent disease activities of RA patients treated with biological DMARDs. Mod Rheumatol 30:293\u2013300. https:\/\/doi.org\/10.1080\/14397595.2019.1602242","journal-title":"Mod Rheumatol"},{"key":"9109_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS13111832","volume":"13","author":"F Ursini","year":"2021","unstructured":"Ursini F, De Giorgi A, D\u2019onghia M et al (2021) Chronobiology and chronotherapy in inflammatory joint diseases. Pharmaceutics 13:1832. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13111832","journal-title":"Pharmaceutics"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09109-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-09109-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-09109-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T15:19:27Z","timestamp":1738682367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-09109-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9109"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-09109-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study was approved by the Ethical Committee of Human Rights in Research at the Faculty of Medicine, Menoufia University with approval number DERM 39\/2022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants were given a clear explanation of the study\u2019s nature and purpose, and written consent was acquired before the study began.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"142"}}